Lose Weight With Semaglutide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist prescribed as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with a body mass index (BMI) that is >27. GLP-1 is a hormone that is produced in the small intestine that stimulates insulin secretion and inhibits glucagon secretion thereby lowering blood sugar.
Studies have demonstrated that Semaglutide reduced appetite, improved control of eating, reduced food cravings and improved glycemic control. The greatest weight loss benefits were observed when Semaglutide is used with lifestyle changes, such as improved diet and consistent exercise.
What are the Benefits of Semaglutide?
- Weight loss/lower BMI
- Improved fertility/treatment of PCOS
- Decreased risk for cardiovascular disease and lowered levels of triglycerides
- Improved sleep
- Improved mood and self esteem
- Decreased blood sugar/A1C and improves insulin resistance
- Reduced risk of stroke and heart attack
- Decreased joint pain/pressure on joint
- Reduce inflammation
What are commonly reported side effects of Semaglutide?
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Headache
- Fatigue
- Upset stomach/stomach pain
- Dizziness
- Belching
- Injection site reaction
What do I need to do to reduce side effects while taking Semaglutide?
- Eat a fibrous diet. Focus on fruits and vegetables that are high in fiber. Daily fiber drinks can be beneficial (Metamucil, psyllium husk, etc.)
- Eat small high protein meals as digestion is slowed down while on this medication
- Avoid foods high in fat as they take longer to digest
- Limit alcohol intake as this medication can lower blood pressure
- Drink at least 64oz of water a day to avoid constipation
- Drink peppermint tea or ginger products to help alleviate nausea
- Add movement such as walking
- Avoid lying down after eating meals
You CANNOT take Semaglutide if you have any of the following conditions.
- Personal or family history of Medullary Thyroid Carcinoma (MTC)
- Personal or family history of Multiple Endocrine Neoplasia Type 2 (MEN 2)
- Prior allergic reaction to Semaglutide or to any of its ingredients
- Diabetic retinopathy (diabetic eye disease)
- Pregnant or trying to get pregnant
- Breast-feeding (Semaglutide is present in breast milk)
- Less than 18 years old
- Depression with a history of suicidal ideations
- Personal history of pancreatitis
